《原发性肝癌诊疗规范(2017年版)》解读  

Interpretation of guidelines for diagnosis and treatment of primary liver cancer(2017 edition)

作　　者：李民 熊俊[1] LI Min;XIONG Jun(Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China)

机构地区：[1]华中科技大学同济医学院附属协和医院肝胆外科

出　　处：《中国普通外科杂志》2019年第7期785-789,共5页China Journal of General Surgery

基　　金：国家自然科学基金资助项目(81502527;81874208)

摘　　要：原发性肝癌是肝脏最常见的恶性肿瘤,其在我国发病率仍居恶性肿瘤的第4位,肿瘤相关死亡第2位。根据循证医学的基本原则,在2011年版规范的基础上结合近年来肝细胞癌诊疗进展,卫计委更新相关建议,制定了原发性肝癌诊疗规范(2017年版)。笔者从肝细胞癌的筛查、诊断、分期和治疗等方面对该规范的诊疗要点和更新进行解读。Primary liver cancer is the most common malignant tumor of the liver. In China, it is still the fourth most common malignant tumor and the second cause of cancer-related death. According to the basic principles of evidencebased medicine, the National Health and Family Planning Commission of the People’s Republic of China updated the relevant recommendations and released the guidelines for diagnosis and treatment of primary liver cancer(2017 edition), on basis of 2011 edition combined with the progress of diagnosis and treatment of hepatocellular carcinoma in recent years. The authors interpret the main points and updates of the guidelines in terms of screening, diagnosis, staging and treatment of hepatocellular carcinoma.

关 键 词：癌 肝细胞 指南 解读 

分 类 号：R735.7[医药卫生—肿瘤]